Yew Bio-Pharm Group, Inc. Segment Reporting Information, Net Assets (Deprecated 2013-01-31)
Yew Bio-Pharm Group, Inc. had Segment Reporting Information, Net Assets (Deprecated 2013-01-31) of $15.93 million as of 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Notes › Segment Reporting
us-gaap:SegmentReportingInformationNetAssets · last filed 2013-05-14
- 2013-03-31: Segment Reporting Information, Net Assets (Deprecated 2013-01-31) $15.93M.
- 2012-12-31: Segment Reporting Information, Net Assets (Deprecated 2013-01-31) $16.21M.
- 2012-09-30: Segment Reporting Information, Net Assets (Deprecated 2013-01-31) $15.87M.
- 2012-06-30: Segment Reporting Information, Net Assets (Deprecated 2013-01-31) $15.82M.
| Period end | Segment Reporting Information, Net Assets (Deprecated 2013-01-31) |
|---|---|
| 2013-03-31 | $15.93M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $16.21M 10-Q · filed 2013-05-14 |
| 2012-09-30 | $15.87M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $15.82M 10-Q/A · filed 2012-09-14 |
| 2011-12-31 | $15.95M 10-K · filed 2013-04-11 |